PHParker Hicks

Parker Hicks

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Parker Hicks has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Large-scale automated detection reveals pervasive sex imbalance in biomedical research

    by Lydia E. Valtadoros, Parker Hicks, Hao Yuan, Mansooreh Ahmadian, Kayla A. Johnson, Arjun Krishnan

    Sex is a critical biological variable that impacts disease risk, progression, and treatment response across virtually every organ system. However, decades of biomedical research have relied primarily on male study subjects, leaving large gaps in our understanding of female-specific disease biology. Quantifying the extent of this imbalance across thousands of disease areas and millions of publicly available biological samples has remained computationally intractable. Here, we present a multimodal computational framework that infers the biological sex of ∼230,000 publicly available human transcriptome samples and links inferred sex labels to disease terms extracted from ∼9,000 associated study records and ∼5,000 publication abstracts to quantify sex imbalance at scale. Applying this approach revealed that the majority of disease terms with the largest research-derived sex imbalance are skewed toward male representation, including areas with no known biological justification for that imbalance. After adjusting for global sex-specific disease prevalence to isolate biologically unjustified imbalance, up to 58% of all disease terms showed male-leaning association. Diseases including glioblastoma, cirrhosis, idiopathic pulmonary fibrosis, and schizophrenia emerged as critically understudied in females despite affecting both sexes comparably. These findings provide a principled, data-driven basis for prioritizing compensatory research efforts and offer a reusable framework for ongoing monitoring of sex representation in the biomedical literature. Highlights: Skewed male and female study subject representation in biomedical research is the result of decades of studies conducted without adequate female representation. We developed an automated, multimodal framework to estimate the sex imbalance across thousands of disease terms using metadata from ∼230,000 transcriptomics samples and their associated ∼9,000 studies and ∼5,000 publications. Our approach identifies non-sex-specific disease research areas that have been studied using an unbalanced sex demographic. These areas need compensatory and balanced studies to understand sex differences.

  • Open Access

    Annotating publicly-available samples and studies using interpretable modeling of unstructured metadata

    by Hao Yuan, Parker Hicks, Mansooreh Ahmadian, Kayla Johnson, Lydia Valtadoros, Arjun Krishnan

    Reusing massive collections of publicly available biomedical data can significantly impact knowledge discovery. However, these public samples and studies are typically described using unstructured plain text, hindering the findability and further reuse of the data. To combat this problem, we propose txt2onto 2 . 0 , a general-purpose method based on natural language processing and machine learning for annotating biomedical unstructured metadata to controlled vocabularies of diseases and tissues. Compared to the previous version ( txt2onto 1 . 0 ), which uses numerical embeddings as features, this new version uses words as features, resulting in improved interpretability and performance, especially when few positive training instances are available. Txt2onto 2 . 0 uses embeddings from a large language model during prediction to deal with unseen-yet-relevant words related to each disease and tissue term being predicted from the input text, thereby explaining the basis of every annotation. We demonstrate the generalizability of txt2onto 2 . 0 by accurately predicting disease annotations for studies from independent datasets, using proteomics and clinical trials as examples. Overall, our approach can annotate biomedical text regardless of experimental types or sources. Code, data, and trained models are available at https://github.com/krishnanlab/txt2onto2.0 . Key points: We developed txt2onto 2 . 0 , a computational method that combines language models and machine learning to annotate public samples and studies with standardized tissue and disease terms, with a focus on interpretability and explainability. Txt2onto 2 . 0 uses word/phrase occurrence statistics to represent sample/study metadata, train machine learning models, and predict terms in controlled vocabularies to annotate each sample and study. This approach allows the model to keep track of predictive words related to model decisions and easily separate informative from uninformative words. Txt2onto 2 . 0 outperforms its predecessor, txt2onto 1 . 0 , in tissue and disease annotation, especially when training data is limited. The predictive features learned by txt2onto 2 . 0 are highly interpretable. These features not only include explicit mentions of the actual disease or tissue terms but also related biomedical concepts, including words that are unseen by the model during training. Although trained on metadata of transcriptomes, txt2onto 2 . 0 is capable of annotating disease and tissue for any kind of biomedical metadata, making it a versatile tool for sample and study annotation.